• Intellia, Regeneron, Viatris + Oyster Point

  • Nov 16 2022
  • Length: 10 mins
  • Podcast
Intellia, Regeneron, Viatris + Oyster Point  By  cover art

Intellia, Regeneron, Viatris + Oyster Point

  • Summary

  • More CRISPR data, oncology wins, and a new player in ophthalmology

    Find out more at
    https://LifeScienceTodayPodcast.com

    Story References
    Intellia
    Regeneron
    Viatris + Oyster Point

    About the Show
    Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry. 

    Show more Show less

What listeners say about Intellia, Regeneron, Viatris + Oyster Point

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.